In a breakthrough discovery, scientists claim that detection of cancer tumors in blood could help doctors customize the treatment for individual patients, making it much simpler and cost-effective.
Researchers at Johns Hopkins University in Baltimore, America established that tests would scan ‘genetic fingerprints’ of the patients to spot early signs of cancer along with its recurrence.
Lead researcher, Victor E. Velculescu, MD, PhD, Johns Hopkins University, who presented the study at American Association for the Advancement of Science meeting, San Diego said, “This is a great tool towards made-to-measure cancer care.”
“This will be a step towards cancer becoming a manageable chronic disease rather than an acute terminal disease,” added Velculescu.